Study on Cognitive Disorders of Multiple Sclerosis

NCT01074619 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

University Hospital, Caen

Collaborators

[object Object]
[object Object]